Canagliflozin approved for type 2 diabetes.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Volumn 70, Issue 10, 2013, Pages 834-

  Traynor, Kate ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CANAGLIFLOZIN; GLUCOSIDE; THIOPHENE DERIVATIVE;

CLINICAL TRIAL (TOPIC); DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DRUG APPROVAL; GLUCOSIDES; HUMANS; HYPOGLYCEMIC AGENTS; THIOPHENES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

MLCS; MLOWN;

EID: 84886829422     PISSN: None     EISSN: 15352900     Source Type: None    
DOI: 10.2146/news130035     Document Type: Note

References (0)